Prognostic Factors of Disease Recurrence and Overall Survival Following Curative Resection of Colon Cancer: A 10-year Cohort from a Referral Center

Background: The growing incidence of colorectal cancer around the world highlights the significance of tumor recurrence and patient survival as 2 key elements of patient therapy. We aimed to study the factors linked with disease recurrence and survival in colon cancer. Methods: Patients with colon cancer who underwent tumor excision as their primary treatment were enrolled in this prospective cohort and monitored for 10 years. Various demographic and clinicopathologic factors of these patients were studied in association with the 2 primary outcomes of this study, including tumor recurrence and patient survival. Statistical tests and survival analysis were utilized to explore the study aims. Results: An overall number of 113 patients were included in this survey with a mean age of 54.7 (±SD, 14.1), and most of the patients were men (56.6%). The mean follow-up period was 28.3 (±25.5) months. Tumor recurrence occurred in 32 (28.3%) patients in the study period. The estimated mean survival of patients was 54.9 (95% CI, 45.3-64.4) months. N staging ( p = 0.036), T staging ( p = 0.009), and pathologic staging (P = .004) were the significant pathological factors to higher tumor recurrence and lower survival rates. Conclusion: Advanced tumor staging led to increased disease recurrence and lower survival of colon cancer patients in this survey. Further public health screening and education programs are needed to improve the early detection and prognosis of these patients in Iran.

[1]  Javad Khanali,et al.  National and Subnational Cancer Incidence for 22 Cancer Groups, 2000 to 2016: A Study Based on Cancer Registration Data of Iran , 2021, Journal of cancer epidemiology.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  H. Salehiniya,et al.  Associated Factors of Survival Rate and Screening for Colorectal Cancer in Iran: a Systematic Review , 2019, Journal of Gastrointestinal Cancer.

[4]  M. Moosazadeh,et al.  Determining the Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis , 2018, Asian Pacific journal of cancer prevention : APJCP.

[5]  B. Glimelius,et al.  Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population , 2018, Diseases of the colon and rectum.

[6]  A. Nahvijou,et al.  Economic burden of colorectal cancer in Iran in 2012 , 2017, Medical journal of the Islamic Republic of Iran.

[7]  Ahmed Kamel,et al.  Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  Jalal Moludi,et al.  Colorectal cancer in Iran: Epidemiology and morphology trends , 2016, EXCLI journal.

[9]  K. He,et al.  Response to RE: Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up , 2016, Supportive Care in Cancer.

[10]  M. Zali,et al.  Recurrence and Five -Year Survival in Colorectal Cancer Patients After Surgery , 2015, Iranian journal of cancer prevention.

[11]  M. Mohammadianpanah,et al.  AN OVERVIEW OF CLINICAL AND PATHOLOGICAL CHARACTERISTICS AND SURVIVAL RATE OF COLORECTAL CANCER IN IRAN , 2014 .

[12]  C. Yau,et al.  Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations , 2013, The American Journal of Gastroenterology.

[13]  J. Kim,et al.  Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer , 2012, Journal of the Korean society of coloproctology.

[14]  S. Beheshti,et al.  Epidemiological differences between colon cancer and rectum cancer. , 2010 .

[15]  Jaw-Yuan Wang,et al.  Predictive factors of early relapse in UICC stage I–III colorectal cancer patients after curative resection , 2009, Journal of surgical oncology.

[16]  M. Akbari,et al.  Survival of colorectal cancer in Iran. , 2009, Asian Pacific journal of cancer prevention : APJCP.

[17]  J. Griggs,et al.  Obesity and cancer treatment: weighing the evidence. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Y. Cho,et al.  Local recurrence after curative resection in patients with colon and rectal cancers , 2008, International Journal of Colorectal Disease.

[19]  M. Zali,et al.  Prognostic factors in 1,138 Iranian colorectal cancer patients , 2008, International Journal of Colorectal Disease.

[20]  Y. Cho,et al.  Clinical and Pathologic Evaluation of Patients with Recurrence of Colorectal Cancer Five or More Years After Curative Resection , 2007, Diseases of the colon and rectum.

[21]  Wai Lun Law,et al.  Prognostic Factors Affecting Survival and Recurrence of Patients with pT1 and pT2 Colorectal Cancer , 2007, World Journal of Surgery.

[22]  F. Granath,et al.  Colon cancer management and outcome in relation to individual hospitals in a defined population , 2007, The British journal of surgery.

[23]  R. Beart,et al.  The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[24]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  M. Brouwers,et al.  Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  K. Yoshimura,et al.  Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection , 2003, Journal of surgical oncology.

[27]  C. Earle,et al.  Follow-up of patients with curatively resected colorectal cancer: a practice guideline , 2003, BMC Cancer.

[28]  J. Church,et al.  Factors Affecting Local Recurrence of Colonic Adenocarcinoma , 2002, Diseases of the colon and rectum.

[29]  J. Fleshman,et al.  Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. , 2002, Journal of the American College of Surgeons.

[30]  H. Ueno,et al.  Criteria for extramural perineural invasion as a prognostic factor in rectal cancer , 2001, The British journal of surgery.

[31]  D. Obrand,et al.  Incidence and patterns of recurrence following curative resection for colorectal carcinoma , 1997, Diseases of the colon and rectum.

[32]  M. Pescatori,et al.  Outcome of colorectal cancer , 1987, The British journal of surgery.

[33]  R C Newland,et al.  Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. , 1983, The Australian and New Zealand journal of surgery.

[34]  R. Million,et al.  Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum , 1976, Cancer.

[35]  M. Khodadost,et al.  Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis , 2019, Asian Pacific journal of cancer prevention : APJCP.

[36]  F. Safavi,et al.  Prevalence of local recurrence of colorectal cancer at the Iranian Cancer Institute. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[37]  M. Zali,et al.  Colorectal cancer in Iran: an epidemiological study. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[38]  K. Shirouzu,et al.  Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. , 2007, Surgery.